ClassActionAmerica.com:  Your Class Action and Product Recall Clearinghouse
search

















Automotive Class ActionsCivil Rights Class ActionsConsumer Products Class ActionsCredit / Debt Class ActionsDrugs / Medical Class ActionsEmployment / Labor Class ActionsEnvironmental Class ActionsFamily Related Class ActionsGovernment Class ActionsInsurance Class ActionsMoney / Stocks Class ActionsRetirement Class ActionsTechnology / Internet Class ActionsTelecommunications Class ActionsTravel Class Actions

in search results


Paxil Antidepressant Medication Users v GlaxoSmithKline Plc

Case Category Amount Available Date Filed Stage
Drugs / Medical No amount specified 8/24/2001 Filing  
 
Paxil Users Claim Maker Hid Drug's Addictive Nature
 
A class action has been filed against GlaxoSmithKline Plc, the British pharmaceutical giant that makes the antidepressant Paxil (paroxetine), on behalf of all people in the United States who were prescribed Paxil and who later suffered withdrawal reactions when they attempted to stop taking the drug.The action claims that GlaxoSmithKline knew that some patients prescribed Paxil would suffer severe withdrawal reactions but failed to warn patients or physicians of this danger. The action asserts claims for fraud and deceit, negligence, strict liability, and breach of warranty. Both compensatory and punitive damages are sought.

Withdrawal reactions suffered by patients attempting to discontinue Paxil include jolting electric "zaps," dizziness, light-headedness, vertigo, lack of coordination, gait disturbances, sweating, extreme nausea, vomiting, high fever, abdominal discomfort, flu symptoms, anorexia, diarrhea, agitation, tremulousness, irritability, aggression, sleep disturbance, nightmares, tremor, confusion, memory and concentration difficulties, lethargy, malaise, weakness, fatigue, paraesthesias, ataxia, and myalgia.

Paxil, which was introduced into the U.S. market on December 29, 1992, is a well known antidepressant medication in the same class as Zoloft and Prozac (selective serotonin reuptake inhibitors, or SSRIs). Paxil is approved for marketing in the U.S. for conditions such as depression, obsessive compulsive disorder, panic disorder, and social anxiety disorder.

According to the plaintiffs, GlaxoSmithKline has known for years that the distinct characteristics of Paxil make it prone to cause withdrawal reactions when discontinued. According to World Health Organization data obtained by the class members, Paxil has the highest rate of adverse experiences during withdrawal of any antidepressant drug in the world.

Related Cases

Prozac, Zoloft, and Paxil Antidepressant Users v Eli Lilly, Pfizer, and GlaxoSmithKline
Some 200 legal actions have been filed against Eli Lilly, Pfizer, and GlaxoSmithKline, the manufacturers of Prozac (fluoxetine), Zoloft (sertraline), and Paxil (paroxetine), respectively, to recover for suicides or homicides--some completed, some only attempted--by patients in the first few days or weeks after they were prescribed one of these drugs.



 

 

 
Legal actions listed on this site are in varying procedural stages. Some actions may be in an investigative stage and not yet filed in a court, while others might be individual or consolidated actions that have not been certified by a court as a class action.
ClassActionAmerica.comsm is a service of the Kahn Gauthier Law Group, LLC
2000 - 2002 Copyright. All rights reserved Kahn Gauthier Law Group, LLC.
Patent Pending Kahn Gauthier Law Group, LLC